Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,950.80
(
0.90%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
-2.31%
)
Bitcoin
78,102.98
(
2.32%
)
News Focus
News Focus
Post# of 824026
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sentiment_stocks

Send PM Follow Ignore
Followers 239
Posts 15508
Boards Moderated 1
Alias Born 03/29/2014

sentiment_stocks

Member Level

Re: H2R post# 471830

Friday, 05/13/2022 2:53:58 AM

Friday, May 13, 2022 2:53:58 AM

Post# of 824026
Thanks for sharing H2R. Very interesting observation. And it’s logical to think that of the lost to follow up, most of those ECA patients did not go off to live long lives, made even more likely due to the fact they were in the control arm of these trials, without even access to the treatment being tested.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News